YAP1 and neoplasm: Unlike in non-small cell lung cancer (NSCLC) cases, where YAP1 is strongly expressed and contributes to oncogenic processes, YAP1 in SCLC appears to correlate with limited-stage disease, an inflamed tumor microenvironment, and improved prognosis [26,44].